http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df17aaf888572918a47cc171273ee9cc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | J. Greenblatt Greenblatt |
| name | David J. Greenblatt David J Greenblatt |
| given-name | David J David J. David |
| organization-name | Sheri L. Spunt, Victor M. Santana, Richard J. Gilbertson, St Jude Children's Research Hospital; Sheri L. Spunt, Victor M. Santana, University of Tennessee Health Science Center, Memphis, TN; Stephan A. Grupp, Children's Hospital of Philadelphia, Philadelphia; Joseph P. Boni, Pfizer, Collegeville, PA; Terry A. Vik, Riley Hospital for Children, Indianapolis, IN; David J. Greenblatt, Tufts University School of Medicine, Boston; Jill Clancy, Revathi Ananthakrishnan, inVentiv Clinical Solutions; and Anna... Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Boston, MA, USA,; Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA Tufts University School of Medicine 36 Harrison Avenue Boston MA 02111 USA From the Departments of Neurology, Boston University School of Medicine and Boston Veterans Administration Medical Center (Drs. Browne and Feldman, Ms. Allen, Ms. Fawcett-Vickers, Mr. Szabo, Ms. Mattson, and Ms. Norman), Boston, MA; Clinical Research Department, Warner-Lambert Parke-Davis Company (Dr. Buchanan), Ann Arbor, MI; Departments of Psychiatry and Medicine, Tufts University School of Medicine (Dr. Greenblatt), Boston, MA. Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center Hospital. Program in Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA American College of Clinical Pharmacology Ashburn VA USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts, U.S.A. Program in Pharmacology and Drug Development, Tufts University School of Medicine and Graduate School of Biomedical Sciences, Boston, MA, USA Tufts University School of Medicine, Boston, MA, USA. Program in Pharmacology and Drug Development Tufts University School of Medicine Boston MA USA Boston MA Graduate Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences and Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, USA Tufts University School of Medicine Boston Massachusetts 02111 Program in Pharmacology and Experimental Therapeutics Sackler School of Graduate Biomedical Sciences, Tufts University Boston; Department of Molecular Physiology & Pharmacology Tufts University School of Medicine Boston MA USA Tufts University School of Medicine Boston, MA USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA Professor of Pharmacology, Psychiatry, and Medicine, Division of Clinical Pharmacology, Tufts University School of Medicine, and New England Medical Center, Boston. Massachusetts. Sackler Program in Pharmacology and Experimental Therapeutics Sackler School of Graduate Biomedical Sciences Boston MA USA Received from the Division of Clinical Pharmacology, Departments of Psychiatry and Medicine Tufts–New England Medical Center Boston Massachusetts The Division of Clinical Pharmacology, Tufts-New England Medical Center, Boston, USA From the Clinical Pharmacology Unit, Department of Medicine, Massachusetts General Hospital, and the Centre de Recherche Merrell International, Strasbourg, France (address reprint requests to Dr. Greenblatt at the Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, MA 02114). Program in Pharmacology and Drug Development Tufts University School of Medicine and Graduate School of Biomedical Sciences Boston Massachusetts USA; Clinical and Translational Sciences Institute Tufts Medical Center Boston Massachusetts USA Tufts University School of Medicine Boston Massachusetts USA; The Clinical and Translational Sciences Institute Tufts Medical Center Boston Massachusetts USA Professor and Chair, Department of Pharmacology and Experimental Therapeutics, Tufts University. 136 Harrison Avenue, Tufts University School of Medicine, Boston, MA. Tufts University School of Medicine 136 Harrison Avenue Boston, Massachusetts 02111 Programs in Pharmacology and Drug Development and in Pharmacology and Experimental Therapeutics Tufts University School of Medicine Boston Massachusetts USA Harvard Medical School and Massachusetts Mental Health Center, Boston, Massachusetts Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center Hospital Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA Division of Clinical Pharmacology Box 1007, Tufts-New England Medical Center, 171 Harrison Avenue, Boston MA 02111, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and the Division of Clinical Pharmacology, Tufts-New England Medical Center, Boston, MA, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston MA 02111, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA Master of Science in Biomedical Sciences Program Tufts University School of Medicine Boston Massachusetts USA; Graduate Programs in Pharmacology and Drug Development and in Pharmacology and Experimental Therapeutics Sackler School of Graduate Biomedical Science Tufts University School of Medicine Boston Massachusetts USA From the Department of Neurology (M.D.W., J.B.D.), University of Washington Medical Center, Seattle; Biostatistics Center (E.A.M.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Neurology (Z.S.), Penn State Hershey Medical Center, Hershey, PA; Department of Neurology (A.S.K., N.A., M.E.C.), Neurological Clinical Research Institute, Massachusetts General Hospital, Boston; Program in Pharmacology and Experimental Therapeutics (D.J.G.), Tufts University School of... Clinical Pharmacology in Drug Development Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine; Division of Clinical Pharmacology, Tufts‐New England Medical Center; Massachusetts College of Pharmacy; and ProMedica Clinical Research Center Inc., Boston, Mass, USA Program in Pharmacology and Drug Development, Tufts University School of Medicine, Boston, MA, USA. Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA, USA. Program in Pharmacology and Experimental Therapeutics Sackler School of Graduate Biomedical Sciences Tufts University School of Medicine Boston MA USA Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center Hospital, Boston, U.S.A. Dr. Greenblatt is Assistant in Medicine (Clinical Pharmacology) and Dr. Koch-Weser is Chief, Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Mass. 02114. Dr. Shader is Director of Clinical Psychiatry and Director of the Psychopharmacology Research Laboratory, Massachusetts Mental Health Center, Boston, Mass. All of the authors are also with Harvard Medical School, Boston, Mass., where Dr. Greenblatt is Assistant Professor of Medicine (Clinical Pharmacology), Dr. Shader is Associate... Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center, Boston, MA, U.S.A. Tufts University School of Medicine, Boston, MA, 02111 USA Department of Pharmacology and Experimental Therapeutics and the Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, USA Program in Pharmacology and Experimental Therapeutics, Department of Molecular Physiology and Pharmacology Tufts University School of Medicine and Tufts Medical Center Boston MA USA Program in Pharmacology and Drug Development Tufts University School of Medicine and Tufts Medical Center Boston Massachusetts USA Department of Integrative Physiology and Pathobiology Tufts University School of Medicine Boston MA USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts-New England Medical Center, Boston, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and the Division of Clinical Pharmacology, Tufts-New England Medical Center, Boston, MA 02111, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and New England Medical Center, and the Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass, USA Professor of Anesthesiology, Director, Division of Cardiothoracic Anesthesiology, Duke University, Durham, North Carolina. Editor‐in‐Chief, Tufts University School of Medicine Boston MA 02111 USA Tufts University School of Medicine Boston MA 02111 USA Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine, Boston, MA, USA Tufts University School of Medicine Boston MA USA Division of Clinical Pharmacology, Departments of Psychiatry and Pharmacology, Tufts University School of Medicine and New England Medical Center Hospital, Boston, MA, 02111, USA Tufts University School of Medicine, Boston, Massachusetts Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts Program in Pharmacology and Experimental Therapeutics Tufts University School of Medicine Boston MA USA Program in Pharmacology and Experimental Therapeutics Tufts University School of Medicine and Tufts Medical Center Boston MA USA Program in Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA. DJ.Greenblatt@Tufts.edu. Program in Pharmacology and Drug Development, Tufts University School of Medicine, Boston, MA, USA. DJ.Greenblatt@Tufts.edu. Tufts-New England Medical Center Boston, Massachusetts 02111 Tufts University School of Medicine Boston MA Clinical Pharmacology Unit, Massachusetts General Hospital, Boston From the *Program in Pharmacology and Drug Development, Tufts University School of Medicine, Boston, MA; and †Emerald Lake Safety, Newport Beach, CA. Tufts University School of Medicine Boston Massachusetts USA Program in Pharmacology and Drug Development Tufts University School of Medicine Boston MA USA; Clinical and Translational Science Institute Tufts Medical Center Boston MA USA Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences Tufts University School of Medicine Boston MA USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and the Division of Clinical Pharmacology, New England Medical Center Hospital, Boston, MA Program in Pharmacology and Drug Development, Tufts University School of Medicine, Boston, MA; and Tufts University School of Medicine Boston MA 02111 Master of Science in Biomedical Science Program, Tufts University School of Medicine, Boston, MA; Program in Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA Program in Pharmacology and Experimental Therapeutics, Tufts University School of Medicine. Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and the Division of Clinical Pharmacology, New England Medical Center, Boston, MA, USA; Tufts University School of Medicine Boston, MA 02111, USA Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Science, Tufts University School of Medicine, Boston, MA, USA; Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and the Division of Clinical Pharmacology, New England Medical Center Hospital, Boston, MA, USA Program in Pharmacology and Experimental Therapeutics, and the Program in Pharmacology in Drug Development, Tufts University School of Medicine, Boston, MA; and From the Program in Pharmacology and Experimental Therapeutics Tufts University School of Medicine and Sackler School of Graduate Biomedical Sciences Boston MA USA Department of Program in Pharmacology and Drug Development, Tufts University School of Medicine, Boston, MA, USA Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA; Division of Clinical Pharmacology, Tufts-New England Medical Center, Boston, MA, USA Program in Pharmacology and Experimental Therapeutics; Tufts University School of Medicine; Boston MA USA Department of Pharmacology and Experimental Therapeutics, and the Division of Clinical Pharmacology, Tufts University School of Medicine, New England Medical Center Hospital, Boston, MA Editor‐in‐Chief, Clinical Pharmacology in Drug Development Division of Clinical Pharmacology and Departments of Pharmacology and PsychiatryTufts University School of Medicine and New England Medical CenterBostonMassachusetts02111USA |
Incoming Links
Total number of triples: 772.